Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

Journal of Clinical Oncology

Volumn 16, Issue 6, 1998, Pages 2253-2260

  Gershenwald, Jeffrey E ^a   Colome, Maria I ^a   Lee, Jeffrey E ^a   Mansfield, Paul F ^a   Tseng, Chi ^a   Lee, J Jack ^a   Balch, Charles M ^a   Ross, Merrick I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0031800249     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.6.2253     Document Type: Article

References (22)

1. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992
2. Morton DL, Wen DR, Cochran AJ: Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy or "watch and wait." Surg Oncol Clin North Am 1:247-259, 1992
3. Reintgen DS, Cruse CW, Berman C, et al: An orderly progression of melanoma nodal metastases. Ann Surg 220:759-767, 1994
4. Ross M, Reintgen DS, Balch C: Selective lymphadenectomy: Emerging role of lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 9:219-223, 1993
5. Gershenwald JE, Thompson W, Mansfield PF, et al: Patterns of failure in melanoma patients after successful lymphatic mapping and negative sentinel node biopsy. Presented at the Forty-Ninth Annual Meeting of The Society of Surgical Oncology, Atlanta, GA, March 21-24, 1996 (abstr)
6. Kirkwood JM, Strawderman MH, Ernstoff MS, et al: Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma. The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14:7-17, 1996
7. Thompson JF, McCarthy WH, Bosch CMJ, et al: Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 5:255-260, 1995
8. Reintgen DS, Albertini J, Berman C, et al: Accurate nodal staging of malignant melanoma. Cancer Control 2:405-414, 1995
9. Robert MR, Wen DR, Cochran AJ: Pathological evaluation of the regional lymph nodes in malignant melanoma. Semin Diagn Pathol 10:102-115, 1993
10. Lane N, Lattes R, Malm J: Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults. Cancer 11:1025-1043, 1958
11. Das Gupta TK: Results of treatment of 269 patients with primary cutaneous melanoma: A five-year prospective study. Ann Surg 186:201-209, 1977
12. Cochran AJ, Wen DR, Morton DL: Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. Am J Surg Pathol 12:612-618, 1988
13. Wang X, Heller R, VanVoorhis N, et al: Detection of submicroscopic metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 220:768-774, 1994
14. Ordonez NG, Mannging JT, Brooks TE. Effect of trypsinization on the immunostaining of formalin-fixed, paraffin-embedded tissues. Am J Surg Pathol 12:121-129, 1988
15. Buzaid AC, Ross MI, Balch CM, et al: Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 15:1039-1051, 1997
16. Ross MI: Surgical management of stage I and II melanoma patients: Approach to the regional lymph node basin. Semin Surg Oncol 12:394-401, 1996
17. Albertini JJ, Cruse CW, Rapaport D, et al: Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223:217-224, 1996
18. Gershenwald JE, Tseng C-H, Thompsom W, et al: Improved sentinel lymph node localization in primary melanoma patients with the use of radiolabeled colloid. Surgery 1998 (in press)
19. Krag DN, Meijer SJ, Weaver DL, et al: Minimal-access surgery for staging of melanoma. Arch Surg 130:654-658, 1995
20. Balch CM, Murad TM, Soong S-J, et al: Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 43:883-888, 1979
21. Scheenbaum S, Briele HA, Walker MJ, et al: Cutaneous thick melanoma: Prognosis and treatment. Arch Surg 122:707-711, 1987
22. Reintgen DS, Balch CM, Kirkwood J, et al: Recent advances in the care of the patient with malignant melanoma. Ann Surg 225:1-14, 1997